119 related articles for article (PubMed ID: 21109924)
1. Assessment of angiogenesis by CD105 and nestin expression in peritumor tissue of glioblastoma.
Sica G; Lama G; Anile C; Geloso MC; La Torre G; De Bonis P; Maira G; Lauriola L; Jhanwar-Uniyal M; Mangiola A
Int J Oncol; 2011 Jan; 38(1):41-9. PubMed ID: 21109924
[TBL] [Abstract][Full Text] [Related]
2. Stem cell marker nestin and c-Jun NH2-terminal kinases in tumor and peritumor areas of glioblastoma multiforme: possible prognostic implications.
Mangiola A; Lama G; Giannitelli C; De Bonis P; Anile C; Lauriola L; La Torre G; Sabatino G; Maira G; Jhanwar-Uniyal M; Sica G
Clin Cancer Res; 2007 Dec; 13(23):6970-7. PubMed ID: 18056172
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical evaluation of the microvascular density through the expression of TGF-beta (CD 105/endoglin) and CD 34 receptors and expression of the vascular endothelial growth factor (VEGF) in oligodendrogliomas.
Netto GC; Bleil CB; Hilbig A; Coutinho LM
Neuropathology; 2008 Feb; 28(1):17-23. PubMed ID: 18181830
[TBL] [Abstract][Full Text] [Related]
4. Independent prognostic relevance of microvessel density in advanced epithelial ovarian cancer and associations between CD31, CD105, p53 status, and angiogenic marker expression: A Gynecologic Oncology Group study.
Rubatt JM; Darcy KM; Hutson A; Bean SM; Havrilesky LJ; Grace LA; Berchuck A; Secord AA
Gynecol Oncol; 2009 Mar; 112(3):469-74. PubMed ID: 19135712
[TBL] [Abstract][Full Text] [Related]
5. Endoglin is a better marker than CD31 in evaluation of angiogenesis in glioblastoma.
Behrem S; Zarkovic K; Eskinja N; Jonjic N
Croat Med J; 2005 Jun; 46(3):417-22. PubMed ID: 15861521
[TBL] [Abstract][Full Text] [Related]
6. Progenitor/Stem Cell Markers in Brain Adjacent to Glioblastoma: GD3 Ganglioside and NG2 Proteoglycan Expression.
Lama G; Mangiola A; Proietti G; Colabianchi A; Angelucci C; D' Alessio A; De Bonis P; Geloso MC; Lauriola L; Binda E; Biamonte F; Giuffrida MG; Vescovi A; Sica G
J Neuropathol Exp Neurol; 2016 Feb; 75(2):134-47. PubMed ID: 26792897
[TBL] [Abstract][Full Text] [Related]
7. Correlation between glioblastoma stem-like cells and tumor vascularization.
He H; Niu CS; Li MW
Oncol Rep; 2012 Jan; 27(1):45-50. PubMed ID: 21971709
[TBL] [Abstract][Full Text] [Related]
8. Comparative evaluation of microvessel density determined by CD34 or CD105 in benign and malignant gastric lesions.
Ding S; Li C; Lin S; Yang Y; Liu D; Han Y; Zhang Y; Li L; Zhou L; Kumar S
Hum Pathol; 2006 Jul; 37(7):861-6. PubMed ID: 16784986
[TBL] [Abstract][Full Text] [Related]
9. Identification of a tumor-initiating stem cell population in human renal carcinomas.
Bussolati B; Bruno S; Grange C; Ferrando U; Camussi G
FASEB J; 2008 Oct; 22(10):3696-705. PubMed ID: 18614581
[TBL] [Abstract][Full Text] [Related]
10. Proliferation of vascular smooth muscle cells in glioblastoma multiforme.
Takeuchi H; Hashimoto N; Kitai R; Kubota T; Kikuta K
J Neurosurg; 2010 Aug; 113(2):218-24. PubMed ID: 19929197
[TBL] [Abstract][Full Text] [Related]
11. Endoglin (CD105) expression in angiogenesis of primary hepatocellular carcinomas: analysis using tissue microarrays and comparisons with CD34 and VEGF.
Yao Y; Pan Y; Chen J; Sun X; Qiu Y; Ding Y
Ann Clin Lab Sci; 2007; 37(1):39-48. PubMed ID: 17311868
[TBL] [Abstract][Full Text] [Related]
12. Microvessel density assessment in benign and malignant endometrial changes.
Czekierdowski A; Czekierdowska S; Czuba B; Cnota W; Sodowski K; Kotarski J; Zwirska-Korczala K
J Physiol Pharmacol; 2008 Sep; 59 Suppl 4():45-51. PubMed ID: 18955753
[TBL] [Abstract][Full Text] [Related]
13. The presence of stem cell marker-expressing cells is not prognostically significant in glioblastomas.
Kim KJ; Lee KH; Kim HS; Moon KS; Jung TY; Jung S; Lee MC
Neuropathology; 2011 Oct; 31(5):494-502. PubMed ID: 21269333
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical expression of vascular endothelial growth factor (VEGF) does not correlate with microvessel density in renal cell carcinoma.
Raica M; Cimpean AM; Anghel A
Neoplasma; 2007; 54(4):278-84. PubMed ID: 17822316
[TBL] [Abstract][Full Text] [Related]
15. Nestin expression in osteosarcomas and derivation of nestin/CD133 positive osteosarcoma cell lines.
Veselska R; Hermanova M; Loja T; Chlapek P; Zambo I; Vesely K; Zitterbart K; Sterba J
BMC Cancer; 2008 Oct; 8():300. PubMed ID: 18925963
[TBL] [Abstract][Full Text] [Related]
16. Density of microvessels positive for CD105 (endoglin) is related to prognosis in meningiomas.
Barresi V; Cerasoli S; Vitarelli E; Tuccari G
Acta Neuropathol; 2007 Aug; 114(2):147-56. PubMed ID: 17594108
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Nestin and EGFR in Patients with Glioblastoma Multiforme in a Public Hospital in Iran.
Matini AH; Mofidi Naeini M; Haddad Kashani H; Vakili Z
Asian Pac J Cancer Prev; 2020 Oct; 21(10):2889-2894. PubMed ID: 33112545
[TBL] [Abstract][Full Text] [Related]
18. Prognostic relevance of CD105-assessed microvessel density in laryngeal carcinoma.
Zvrko E; Mikic A; Vuckovic L; Djukic V; Knezevic M
Otolaryngol Head Neck Surg; 2009 Oct; 141(4):478-83. PubMed ID: 19786216
[TBL] [Abstract][Full Text] [Related]
19. Endoglin (CD105) expression and angiogenesis status in small cell lung cancer.
Takase Y; Kai K; Masuda M; Akashi M; Tokunaga O
Pathol Res Pract; 2010 Nov; 206(11):725-30. PubMed ID: 20619547
[TBL] [Abstract][Full Text] [Related]
20. Glioblastoma-dependent differentiation and angiogenic potential of human mesenchymal stem cells in vitro.
Birnbaum T; Hildebrandt J; Nuebling G; Sostak P; Straube A
J Neurooncol; 2011 Oct; 105(1):57-65. PubMed ID: 21547397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
